Bentley Acquires the GoBack Catheter From Upstream Peripheral Technologies

September 13, 2022—Bentley, based in Hechingen, Germany, announced it has acquired the rights of the GoBack catheter from Upstream Peripheral Technologies, which is headquartered in Caesarea, Israel. The device is currently produced in Israel and initially will be shipped from there. Production will transfer to Bentley’s facility in Germany, which will be completed by 2025.

According to Bentley, this acquisition expands the company’s product portfolio, which is dedicated to improving clinical outcomes of endovascular treatments.

Martijn Nugteren, Director Sales & Marketing at Bentley, advised, “We will be really busy in the months ahead. Not only because we want to make the product commercially available in additional markets, but also due to the fact that we are going to rebrand the GoBack to BeBack. This is to make sure that our new product will be recognized as another leading product underneath Bentley’s brand umbrella.”

The GoBack catheter has received CE Mark approval and FDA clearance, which will allow Bentley to enter the United States market sooner than initially planned. Launched in 2019, the device is now available in 23 countries. Bentley intends to extend the global availability to all 80 markets in which the company is active.

The GoBack catheter is designed to simplify crossing and re-entry to treat lesions in the arteries occluded by heavily calcified plaque or stenosis. The device features a curved nitinol needle that can be manipulated by the physician using the device handle. The device's small profile allows it to be used in the smaller arteries in the lower leg.

In January 2022, data were published by Olaf Bakker, MD, et al online ahead of print in the Journal of Endovascular Therapy that demonstrated the effectiveness of the GoBack catheter in crossing difficult peripheral vascular lesions when used to treat patients undergoing complex revascularizations in lower limb arteries (2022;29:798–807).